Why the study?
The European Heart Rhythm Association consensus document provides a patient-tailored pharmacological antiarrhythmic treatment approach addressing arrhythmia mechanisms and drug considerations.
This paper summarizes novel, patient-tailored antiarrhythmic treatment concepts based on the recent EHRA consensus document.
Answers are grounded in this paper and cite their sources.
Supports patient-tailored antiarrhythmic concepts per EHRA; leaves open adoption pending prospective validation.
Clinical implications from the European Heart Rhythm Association consensus document on antiarrhythmic drug therapyThe recently published consensus document by the European Heart Rhythm Association presents a patient-tailored pharmacological antiarrhythmic treatment approach targeting the arrhythmia mechanism.This document comprehensively reviews the indications, side effects, and contraindications of antiarrhythmic drugs.In this paper, we reviewed novel treatment concepts offered by the consensus document.
No takes yet. Share an insight, caveat, or question.
Emin Evren Özcan (2018) conducted a review in Arrhythmia. Antiarrhythmic drug therapy was evaluated. The European Heart Rhythm Association consensus document provides a comprehensive review of indications, side effects, and novel patient-tailored pharmacological antiarrhythmic treatment concepts.
Synapse has enriched 10 related papers. Consider them for comparative context: